Hedges Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Hedges Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$52.5K	Buy	+125,000	New	+$66.3K	0.04%	108

Other funds holding SGMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Hedges Asset Management's SGMO Position: Q4 2025 in Review

Hedges Asset Management opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q4 2025: 125,000 shares worth $52.5K. The stake represents 0.04% of the portfolio and ranks #108 among its holdings.

105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

Hedges Asset Management held 125,000 shares of SANGAMO THERAPEUTICS INC worth $52.5K as of Q4 2025.
SANGAMO THERAPEUTICS INC was a new Hedges Asset Management position in Q4 2025.
SANGAMO THERAPEUTICS INC made up 0.04% of Hedges Asset Management's portfolio in Q4 2025, its #108 holding.
105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on Hedges Asset Management's 13F filing for Q4 2025, filed 27 Jan 2026.